Abstracts and Publications

Dec. 7, 2024, Los Angeles California
Diabetics and Insulin Resistant Patients, Especially Post COVID-19, Have an Increased Biologic Age From Analysis of Brain FDG PET
Diabetics and Insulin Resistant (R) patients have greater risk of cognitive impairment, often exacerbated by COVID-19.
Click here to see the full title in PDF.

Dec. 7, 2024, Los Angeles California
Weight Loss: A Changing Paradigm in Insulin Resistant and Diabetic
Patients
GLP-1 agents increasingly impact obesity therapy of insulin-resistant and diabetic patients.
Click here to see the full title in PDF.

Oct 7, 2017, Birmingham, Alabama
South-Eastern Chapter of Society of Nuclear Medicine
Modified Fractal Analysis of Brain PET and SPECT to Assess Grey and White Matter Function
Click here to see the full title in PDF.

May 3-7, 2017, Austin, Texas
American Association of Clinical Endocrinologists
Insulin Resistance in Adult Type 1 Diabetics: An Increasing Problem With More Severe Liver Disease than Type 2 Diabetics
Click here to see the full title in PDF.

Sept 21-25, 2016, Denver, Colorado
American Thyroid Association
Critical Modulation of Liver Function by the Thyroid Contributes Specifically to Pathogenesis in Multiple Endocrine and Metabolic Disorders
Click here to see the full title in PDF.

May 25-29, 2016, Orlando, Florida
American Association of Clinical Endocrinologists
Comparing Regions of Best and Worst Liver Function Increases Sensitivity to Detect Liver Disease in Insulin Resistant Patients
Click here to see the full title in PDF.

Jan, 2016, Orlando, Florida
Society of Nuclear Medicine and Molecular Imaging
BRAIN-HEART IMAGING WITH N-13 AMMONIA PET: A PRACTICAL CLINICAL PROTOCOL
Click here to see the full title in PDF.

2015, Nashville, Tennessee
American Association of Clinical Endocrinologists
LIVER DISEASE CONTRIBUTES TO COGNITIVE IMPAIRMENT ASSOCIATED WITH INADEQUATE GLYCEMIC CONTROL IN PATIENTS WITH MULTIPLE ENDOCRINE AND METABOLIC ABNORMALITIES
Click here to see the full title in PDF.

Nov 20-22, 2014, Hilton Universal City, Los Angeles, California
One of the 8 finalist award for this abstract
12th World Congress on Insulin Resistance – Diabetes and cardiovascular disease
Recognition of Reversible Liver Disease: A Window of Opportunity in the Metabolic Syndrome Epidemic
Click here to see the full title in PDF.

May 13-18, 2014, Las Vegas, Nevada
American Association of Clinical Endocrinologists
HEPATIC STEATOSIS AND THE DIABETES EPIDEMIC; BIRDS OF A FEATHER
Click here to see the full title in PDF.

November 7-9, 2013
The World Congress of Insulin Resistance, Diabetes and Cardiovascular Disease
Insulin Resistance and Diabetes Mellitus are Frequent Complications in Long Term Follow-Up of Patients with Traumatic Brain Injury
Click here to see the full title in PDF. #1
Click here to see the full title in PDF. #2

April 28-May 2, 2013
First Prize Poster competition American Association of Clinical Endocrinology International Meeting, Phoenix, Arizona
Chronic Pituitary Disease After Traumatic Brain Injury:  Implications of Increased Recognition, Phoenix, Arizona
Review our experience evaluating traumatic brain injury (TBI) patients for pituitary disease and related comorbidities.
Click here to see the full title in PDF.

July 13-18, Boston, Massachusetts
Alzheimer’s Association International Conference, AAIC
Omega 3 Fish Oil with Purified Eicosapentanenoic Acid Also Stimulates Cerebral Perfusion
Click here to see the full title in PDF.

Nov 1-3, 2012, Hollywood, California
World Congress on Insulin Resistance – Diabetes and cardiovascular disease
Insulin Resistance, Diabetes Mellitus and Low Cerebral Flow
Click here to see the full title in PDF.

Nov 1-3, 2012, Hollywood, California
World Congress on Insulin Resistance – Diabetes and cardiovascular disease
Demonstrate abnormal cerebral flow reserve in cognitively impaired insulin resistant (IR) patients and cerebral perfusion stimulation by coconut oil.
Click here to see the full title in PDF.

July, 2012
Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, Volume 8, Issue 4, Supplement
The Product of Normalized Cerebral Metabolic and Cerebral Flow Reserve Factors Accounts for most Variability in Mild Cognitive Impairment and Early Dementia
Click here to see the full title in PDF.

Nov 3-5, 2011
9th Annual World Congress of Insulin Resistance, Diabetes & Cardiovascular Disease, Hollywood, California
Renal Hyperfiltration is Associated with Decreased Cerebral Flow Reserve and Increased Stroke Risk in Patients with Metabolic Syndrome or Diabetes Mellitus.
Click here to see the full title in PDF.

July 16-21, 2011
Alzheimer’s Association International Conference, Paris, France
Corrected Cerebral Flow Reserve from Brain SPECT as a Marker of Dementia Risk
Click here to see the full title in PDF.

April , 2011
American Association of Clinical Endocrinology. San Diego, California
Risk of Stroke in Pituitary Disease: Assessment by a Brain SPECT Index of Cerebral Flow Reserve.
Click here to see the full title in PDF.

February 20, 2011
Cerebrovascular Reserve, Dementia Risk and Renal Function
Increasing evidence implicates brain hypoperfusion as an early and potentially treatable aspect of dementia risk.
Click here to see the full title in PDF.

November 19-22, 2009 a
Vascular Dementia International Conference, Barcelona, Spain.
The Brain Metabolic-Perfusion Index, A New Spect Or Pet Method To Define Dementia   Pathophysiology For Selection And Monitoring Of Optimal Therapy.
Click here to see the full title in PDF.

November 19-22, 2009 b
Vascular Dementia International Conference, Barcelona, Spain.
Cerebral Vascular and Other Pathophysiology Found For High Values of SPECT or PET Derived Cerebrocortical Perfusion and Metabolic Indices.
Click here to see the full title in PDF.

November 19-22, 2009 c
Vascular Dementia International Conference, Barcelona, Spain.
Vascular Dementia Pathophysiology Defined by Brain SPECT Response to Stimulating Cerebral Perfusion.
Click here to see the full title in PDF. 

November 19-22, 2009 d
Vascular Dementia International Conference, Barcelona, Spain.
Vascular Pathophysiology Revealed by Brain SPECT in Patients with Traumatic Brain Injry and Diabetes Mellitus.
Click here to see the full title in PDF. 

Oct. 10, 2009
Brain SPECT use in traumatic brain injury.
Click here to see the full title in PDF. 

September 23-27, 2009
American Thyroid Association International Meeting, West Palm Beach, Florida.
Metal Toxicity Determined by Bioassay of Urine Porphyrins Correlates with Thyroid
Associated Cognitive Impairment and Psychiatric Disease.
Click here to see the full abstract in PDF.

May 14-19, 2009
American Association of Clinical Endocrinology International Meeting Houston, Texas.
PseudoAlzheimer’s Pattern of Brain Metabolism in Thyroid Disease and Mercury
Toxicity Studied by Metabolic Stress Brain SPECT.
Click here to see the full abstract in PDF.

March 16-17, 2009
San Francisco, California.
Stimulated perfusion and basal metabolic SPECT or PET.
Click here to see the full abstract in PDF.

July 28, 2008
Alzheimer’s Association International Research Meeting, Chicago, Illinois.
Brain basal metabolism and flow reserve predict therapeutic response in most
cognitively impaired patients.
Click here to see the full abstract in PDF.

May 14-17, 2008
American Association of Clinical Endocrinology International Meeting, Orlando, Florida.
A new method using a nuclear camera and a direct renin inhibitor (DRI) to screen
for renal artery stenosis (RAS).
Click here to see the full abstract in PDF.

May 14-17, 2008
American Association of Clinical Endocrinology International Meeting, Orlando, Florida.
Compare cerebral metabolism in hyperthyroidism and Alzheimer’s disease.
Click here to see the full abstract in PDF.